A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer. Nadal E, Saleh M, Aix SP, Ochoa-de-Olza M, et al. BMC Cancer 2023;23:708.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nadal E, Saleh M, Aix SP, Ochoa-de-Olza M, et al. A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer. BMC Cancer 2023;23:708.
PMID: 37507657